Senators Question Auto-Injector Price Hikes


Two senators are examining recent price increases of EpiPen®, Mylan NV’s brand of epinephrine auto-injector. Since 2007 when Mylan first acquired the rights to market the device, the price has risen from $57 per auto-injector to over $600 per pair today according to Bloomberg.

Chuck_GrassleySenator Charles Grassley (R) of Iowa called on the company to explain “a steep price increase in the product in recent years.

“The substantial price increase could limit access to a much-needed medication,” Grassley wrote to Mylan Chief Executive officer Heather Bresch in an Aug. 22 letter.

Amy_KlobucharSenator Amy Klobuchar (D) of Minnesota called for an investigation by the Federal Trade Commission (FTC) to determine whether the firm employed anticompetitive practices to deny competitors access to the market. She claimed that though Amedra’s Adrenaclick® provides a less expensive alternative to EpiPen, sales remain low.

Klobuchar urged the FTC to investigate whether Mylan employed exclusionary contracts with insurers, distributors or pharmacies.

“The commission takes seriously its obligation to take action where pharmaceutical companies have violated the antitrust laws and will continue to closely scrutinize drug market competition on consumers’ behalf,” Justin Cole, an FTC spokesman, said in an e-mailed statement.

Note of Disclosure: Mylan is an advertiser with
Print or share this article
Print or share this article
Click to visit sponsor
Dave Bloom
Dave Bloom
Dave Bloom is CEO and "Blogger in Chief" of

Find Allergy-Friendly Products


Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.